This study explored the co-delivery of curcumin (CUR) and resveratrol (RV) using folic acid-
conjugated poly (glycerol adipate)-based nanoparticles (FPPC NPs) to enhance their …

Objective: Docetaxel (DTX) remains the only effective drug for prolonging survival and
improving quality of life of metastatic castration-resistant prostate cancer (mCRPC) patients …

Paclitaxel (PTX) and curcumin (CUR) are potent chemotherapeutic agents used in the
treatment of cancer. In the present study, hybrid polymer–lipid nanoparticles co-loaded with …

In this study, we have aimed to prepare folic acid-conjugated dextran stearate (DF)
polymeric micelles to target resveratrol in lung cancers. The polymeric micelle was …

The development of novel combination anticancer drug delivery systems is an important
step to improve the effectiveness of anticancer treatment in metastatic breast cancer and to …

Curcumin, a functional food polyphenol reported to inhibit cancer cell proliferation, invasion,
angiogenesis and metastasis through interaction with multiple molecular targets. However …

Objective: To overcome both the dose-limiting side effects of conventional chemotherapeutic
agents and the therapeutic failure incurred from multidrug resistant (MDR) in osteosarcoma …

Introduction The failure of chemotherapy in osteosarcoma results in drug resistance and
acute side effects in the body. Methods In this study, we have prepared a novel folate …

Codelivery is a promising strategy to overcome the limitations of single chemotherapeutic
agents in cancer treatment. Despite progress, codelivery of two or more different functional …

Curcumin (CUR) has good antitumor effects, but its poor aqueous solubility severely limits its
clinical application and the systemic nonspecific distribution of the free drug in tumor …